News & Updates
Filter by Specialty:

Anticoagulant use, older age predict radiation proctitis in chemoradiation-treated cervical cancer
Treatment with antiplatelet medications and age are some of the factors associated with the occurrence of radiation proctitis in patients with locally advanced cervical cancer treated by chemoradiation, a recent study has shown.
Anticoagulant use, older age predict radiation proctitis in chemoradiation-treated cervical cancer
31 Jul 2024
RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena
The addition of dostarlimab to a carboplatin-paclitaxel (CP) chemotherapy regimen confers an overall survival (OS) benefit in women with primary advanced or recurrent endometrial cancer (EC), according to the second interim analysis of the ENGOT-EN6/GOG-3031/RUBY trial part 1.
RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena
30 Jul 2024
Is it safe to use conditionally ordered LMWH in cancer patients with VTE?
Conditional orders of low molecular weight heparin (LMWH) based on platelet values appears safe and effective in the treatment of venous thromboembolism (VTE) in patients with malignant haematology (MH) experiencing thrombocytopenia, a study has shown. In addition, worsening or new VTE has not been reported among study participants.